Os tratamentos com placa oclusal, terapia manual e aconselhamento são efetivos na redução da dor e ansiedade de pacientes portadores de disfunção temporomandibular? Ensaio clínico randomizado
Introduction: Anxiety is considered a relevant psychosocial factor in the multifactorial etiology of temporomandibular dysfunction (TMD). Aim: To determine the effect of treatment with occlusal splint (OS), manual therapy (MT), counseling (C) and the association of occlusal splint + counseling (OSC)...
Na minha lista:
Autor principal: | |
---|---|
Outros Autores: | |
Formato: | Dissertação |
Idioma: | por |
Publicado em: |
Brasil
|
Assuntos: | |
Endereço do item: | https://repositorio.ufrn.br/jspui/handle/123456789/24298 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Resumo: | Introduction: Anxiety is considered a relevant psychosocial factor in the multifactorial etiology of temporomandibular dysfunction (TMD). Aim: To determine the effect of treatment with occlusal splint (OS), manual therapy (MT), counseling (C) and the association of occlusal splint + counseling (OSC) in the measurement of pain and anxiety in patients with TMD. Methods: A randomized clinical trial was conducted with 89 patients diagnosed with TMD through RDC / TMD (Research Diagnostic Criteria for Temporomandibular Disorders) and divided into four groups of treatment: OSC (n = 25), OS (n = 24), MT (n = 21) and C (n = 19). Participants were assessed before and after 1 month of therapy for pain, anxiety and TMD diagnosis. Pain measurement was done according to a visual analogue scale (VAS). To assess anxiety, three questionnaires were used: the Hospital Anxiety and Depression Scale (HADS), the Beck Anxiety Inventory (BAI) and the Trait-State Anxiety Index (IDATE-T and E). The data were analyzed using SPSS (Statistical Package for Social Science) 22.0 with the Split Plot ANOVA test and with a confidence level of 95%. Results: Among the participants, there was a predominance of females (82.1%, n = 72) and the mean age was 28 years (± SD = 9.34). The four groups obtained a significant reduction (p <0.001) in the pain variable after 1 month of treatment. The evaluation of anxiety, made with three different questionnaires, showed that there was reduction of anxiety symptoms after 1 month for all groups. However, this reduction was only statistically significant when evaluated over time, HADS (p <0.001), BAI (p <0.001), IDATE-T (p = 0.006), and therefore, there was no significant decrease in symptoms among different treatment groups. Only for the evaluation of state-anxiety by the IDATE-E, no significant reduction was found between the groups (p = 0.068) nor over time (p = 0.760). Conclusion: The results of this study showed that the therapies used were effective in reducing pain and anxiety symptoms in patients diagnosed with TMD. However, no group was superior to the other in reducing the studied variables. |
---|